Related Experiment Video

Updated: May 24, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

p120RasGAP-mediated activation of c-Src is critical for oncogenic Ras to induce tumor invasion

Po-Chao Chan1, Hong-Chen Chen

  • 1Department of Life Sciences, National Chung Hsing University, Taichung, Taiwan.

Cancer Research
|March 14, 2012
PubMed

Insights

Oncogenic Ras mutations activate c-Src kinase, a key driver of tumor invasion. This study identifies p120RasGAP as a crucial mediator in this process, highlighting a new therapeutic target for Ras-driven cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Ras genes are frequently mutated in human cancers, leading to uncontrolled cell growth.
  • Activating mutations in Ras genes are linked to various cancer types.
  • The role of c-Src activation in Ras-driven cancers requires further elucidation.

Purpose of the Study:

  • To investigate the correlation between oncogenic Ras mutations and c-Src activation in human cancer cells.
  • To identify the molecular mechanisms by which oncogenic Ras activates c-Src.
  • To determine the role of p120RasGAP in mediating Ras-induced c-Src activation and subsequent tumor invasion.

Main Methods:

  • Analysis of human cancer cell lines with oncogenic Ras mutations.
  • Immunofluorescence microscopy to visualize protein localization (Golgi complex, endoplasmic reticulum).
  • Co-immunoprecipitation assays to assess protein-protein interactions.

Main Results:

  • A high incidence of correlation was observed between oncogenic Ras mutations and c-Src activation.
  • Oncogenic Ras induces c-Src activation primarily at the Golgi complex and endoplasmic reticulum.
  • p120RasGAP was identified as an effector mediating oncogenic Ras-induced c-Src activation.
  • p120RasGAP recruitment to the Golgi by oncogenic Ras facilitates c-Src interaction and activation.
  • p120RasGAP-mediated c-Src activation is critical for Ras-driven tumor invasion.

Conclusions:

  • Oncogenic Ras activates c-Src through the recruitment and action of p120RasGAP.
  • This Ras-RasGAP-Src signaling axis plays a significant role in promoting tumor invasion.
  • Targeting the c-Src pathway could be a potential therapeutic strategy for cancers with Ras mutations.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...